Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Accumulated Expenses (2019 - 2025)

Historic Accumulated Expenses for Medirom Healthcare Technologies (MRM) over the last 7 years, with Q2 2025 value amounting to $3.2 million.

  • Medirom Healthcare Technologies' Accumulated Expenses rose 27738.62% to $3.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.2 million, marking a year-over-year increase of 27738.62%. This contributed to the annual value of $2.1 million for FY2024, which is 22616.15% up from last year.
  • According to the latest figures from Q2 2025, Medirom Healthcare Technologies' Accumulated Expenses is $3.2 million, which was up 27738.62% from $2.1 million recorded in Q4 2024.
  • Medirom Healthcare Technologies' Accumulated Expenses' 5-year high stood at $7.6 million during Q4 2021, with a 5-year trough of -$1.8 million in Q2 2024.
  • Moreover, its 5-year median value for Accumulated Expenses was $2.1 million (2024), whereas its average is $2.8 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 35214.87% in 2023, then crashed by 12605.62% in 2024.
  • Over the past 5 years, Medirom Healthcare Technologies' Accumulated Expenses (Quarter) stood at $7.6 million in 2021, then crashed by 51.89% to $3.7 million in 2022, then crashed by 82.08% to $656532.1 in 2023, then soared by 226.16% to $2.1 million in 2024, then soared by 48.92% to $3.2 million in 2025.
  • Its Accumulated Expenses stands at $3.2 million for Q2 2025, versus $2.1 million for Q4 2024 and -$1.8 million for Q2 2024.